November 29, 2023
RegMed Investors (RMi) Research Financing Note: Verve Therapeutics (VERV) has priced its public offering of 12.5 M shares at $10.00
November 16, 2023
RegMed Investors (RMi) Research Note: Homology Medicines (FIXX) enters into merger agreement and financing with Q32 Bio Inc. in an all-stock transaction
October 19, 2023
RegMed Investors (RMi) Research Note: Beam Therapeutics (BEAM) reduces headcount
October 18, 2023
RegMed Investors (RMi) Research Note: Ultragenyx Pharmaceutical (RARE) has priced its public offering at $30.00 per share of 8,33 M stock
August 18, 2023
RegMed Investors (RMi) Research Note: Q2/23 net losses earnings, cash positions and runway outcomes
July 31, 2023
RegMed Investors (RMi) Research Note: Q2/2023 earnings reporting date announcements
July 3, 2023
Happy 4th of July and week
June 21, 2023
RegMed Investors (RMi) Research Note: Editas Medicine (EDIT) prices a $125 M offering of 12.5 M shares at $10.00
June 21, 2023
RegMed Investors (RMi) Research Note: UniQure NV (QURE -$8.08 or -41.72% to $11.33) crashed
May 27, 2023
RegMed Investors (RMi) Research Note: Q1/23 earnings reporting dates, net losses, cash positions and runway outcomes
May 15, 2023
UniQure NV (QURE) to sell royalty interest in blood disorder therapy for up to $400 M
April 10, 2023
RegMed Investors (RMi) Research Note: Q4 and FY22 earnings reporting
March 17, 2023
RegMed Investors (RMi) Research Note: Silicon Valley Bank Group (SIVB) files for bankruptcy
March 13, 2023
RegMed investors (RMi) Research Note: the aftermarket of catching a falling knife without a cut or slash
March 12, 2023
RegMed Investors: Special from Gleneagles, a luxury golf resort in Scotland, and spoke from a room framed by dark cabinets.
February 28, 2023
RegMed Investors (RMi) Research Note: Upcoming Q4 earnings reporting dates
February 8, 2023
Cellectis SA (CLLS) closes 9.9 M ADS offering at $2.50
January 25, 2023
Precigen (PGEN) $75 M offering priced at $1.75
January 24, 2023
Verastem Oncology (VSTM) $60 M Private Placement Offering of Series B Convertible Preferred Stock
January 18, 2023
bluebird bio (BLUE) prices offering of 20 M shares at $6.00
January 9, 2023
RegMed Investors (RMi) Research Note: News related to JPM23
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors